News

Immunotherapy Reception on Parliament Hill – It’s In You To Fight Cancer!

The Canadian Cancer Survivor Network (CCSN) thanks everyone who attended our breakfast event, It’s In You to Fight Cancer, on Parliament Hill in Ottawa on June 12, 2018. We were lucky to have Rob Oliphant, Member of Parliament (MP) for Don Valley West, host the event in the beautiful Parliamentary Dining room of Center Block. Over

Read More

Take the All.Can Cancer Patient Survey!

You CAN help to shape the future of cancer care! Take this short patient survey to help us gather insights on where gaps and waste occur, and how cancer care could be improved. Findings will inform policy discussions on improving cancer care for all. Please share your thoughts, to ensure the patient voice can be

Read More

Ottawa Mayor Jim Watson proclaims June as National Cancer Survivors Month

For immediate release: OTTAWA, ON – On June 4th, 2018, Ottawa Mayor Jim Watson proclaimed National Cancer Survivors Month in recognition of over one million cancer survivors living in Canada today. This proclamation took place at City Hall in the presence of representatives of the Canadian Cancer Survivor Network. The co-chairman of Prostate Cancer Canada

Read More

Click here to watch our most recent webinar! Car T-Cell Therapy

In this webinar: A novel cancer treatment that engineers our own immune cells to kill cancer. Dr. Jim Whitlock explains Chimeric Antigen Receptor T-cell (CAR-T) therapy, and the emerging challenges and concerns related to its use within the scope of Childhood Acute Lymphoblastic Leukemia. The webinar was followed by an interactive question and answer session.

Read More

CCSN Submission to Senate on Bill C-45

On May 11th 2018, CCSN provided a submission to members of the Standing Senate Committee on Social Affairs, Science and Technology. The submission was a review of Bill C-45, An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts (Cannabis Act). It provides CCSN’s perspectives about

Read More

Diffuse Large B Cell Lymphoma (DLBCL) Patient Survey

If you have or had Diffuse Large B Cell Lymphoma (DLBCL), you can help by completing Lymphoma Canada’s survey. Lymphoma Canada is preparing a submission for the pan-Canadian Oncology Drug Review (pCODR). The survey provides us with the patient input required for the submission. pCODR uses this information to help them make recommendations to Canadian

Read More